Background Delirium can occur in patients with pneumonia, but its prevalence is inconsistent across studies. Unreliable estimates and uncertainty regarding the significance of patient-specific vs. microbiological risk factors hinder delirium management and prognosis. Here, we provide robust estimates of delirium prevalence in patients with pneumonia, associated risk factors, and association with mortality.
Methods We searched five databases (MEDLINE, Cochrane Library, Embase, PsycINFO, and Scopus), from inception to August 6, 2024. We included studies in adults hospitalized with pneumonia reporting delirium, encephalopathy, or altered mental status. Two investigators extracted data and assessed risk of bias. Summary rates were calculated using random-effects models. We performed prespecified analyses for diagnostic methods, microbiologic factors, clinical factors, and mortality, with sensitivity analysis among studies at low risk of bias. Registration: PROSPERO-CRD42023385571.
Results Delirium prevalence across 126 studies was 22% (95% CI [18%–26%]), and higher in studies at low risk of bias (40% [24%–58%], n=11). Standardized assessments yielded higher rates than symptom-or ICD code-based assessments (p<0.05). Surprisingly, delirium rates did not differ by microbiological etiology (p=0.63), including COVID-19, nor by pneumonia origin (p=0.14). Predisposing factors included older age and neurologic and systemic comorbidities. Delirium was associated with increased mortality (OR 4.3 [3.24–5.76], p<0.001), without change over five decades (p = 0.32).
Interpretation Delirium is highly prevalent and enduring in pneumonia. Our results emphasize patient-and care-related factors over microbiological causes, including COVID-19. Delirium’s entrenched association with mortality, even considering covariates, reinforces the need to manage delirium as a convergent syndrome in pneumonia.
Take-home message (shareable abstract) Delirium rates in pneumonia vary widely across studies. This meta-analysis establishes that delirium is common in pneumonia, driven by patient and care related factors rather than microbiology including COVID-19, and consistently associated with mortality.
Competing Interest StatementThe authors have declared no competing interest.
Funding StatementThis study was funded by NIH-NIA (R01-AG0782611) to EYK and NIH (U19AI135964, PO1HL154998, U19AI181102) to RGW.
Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The source data (papers for meta-analysis) were openly available before the initiation of the study and can be obtained through literature based databases. Ovid MEDLINE: https://www.wolterskluwer.com/en/solutions/ovid/ovid-medline-901 Cochrane Central Register of Controlled Trials: https://www.cochranelibrary.com/central/about-central Embase: https://www.embase.com/ PsycINFO: https://www.apa.org/pubs/databases/psycinfo Scopus: https://www.scopus.com/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data AvailabilityAll data produced in the present study are available upon reasonable request to the authors
Comments (0)